|
extraocular skeletal muscle development
|
GO:0002074 |
1 |
1.000
|
|
|
forebrain dorsal ventral pattern formation
|
GO:0021798 |
1 |
0.998
|
|
|
negative regulation of transcription from rna polymerase ii promoter
|
GO:0000122 |
281 |
0.982
|
|
|
gas transport
|
GO:0015669 |
3 |
0.958
|
|
|
regulation of ureteric bud formation
|
GO:0072106 |
1 |
0.945
|
|
|
forebrain regionalization
|
GO:0021871 |
3 |
0.879
|
|
|
glycerol transport
|
GO:0015793 |
5 |
0.813
|
|
|
one carbon compound transport
|
GO:0019755 |
4 |
0.799
|
|
|
specification of organ identity
|
GO:0010092 |
3 |
0.726
|
|
|
positive regulation of ureteric bud formation
|
GO:0072107 |
1 |
0.600
|
|
|
heart development
|
GO:0007507 |
95 |
0.506
|
|
|
segmentation
|
GO:0035282 |
4 |
0.484
|
|
|
cranial nerve development
|
GO:0021545 |
4 |
0.441
|
|
|
neuron fate commitment
|
GO:0048663 |
2 |
0.410
|
|
|
pituitary gland development
|
GO:0021983 |
2 |
0.402
|
|
|
negative regulation of cell differentiation
|
GO:0045596 |
171 |
0.393
|
|
|
carbon dioxide transport
|
GO:0015670 |
3 |
0.375
|
|
|
brain development
|
GO:0007420 |
97 |
0.361
|
|
|
positive regulation of developmental process
|
GO:0051094 |
314 |
0.336
|
|
|
mesonephric tubule formation
|
GO:0072172 |
1 |
0.330
|
|
|
pancreatic juice secretion
|
GO:0030157 |
4 |
0.324
|
|
|
regulation of branching involved in ureteric bud morphogenesis
|
GO:0090189 |
3 |
0.307
|
|
|
organ morphogenesis
|
GO:0009887 |
147 |
0.283
|
|
|
photoreceptor cell differentiation
|
GO:0046530 |
2 |
0.281
|
|
|
nerve development
|
GO:0021675 |
4 |
0.279
|
|
|
ureteric bud formation
|
GO:0060676 |
1 |
0.259
|
|
|
organ formation
|
GO:0048645 |
3 |
0.239
|
|
|
regulation of organ formation
|
GO:0003156 |
4 |
0.239
|
|
|
negative regulation of developmental process
|
GO:0051093 |
247 |
0.236
|
|
|
organic hydroxy compound transport
|
GO:0015850 |
63 |
0.233
|
|
|
circulatory system development
|
GO:0072359 |
262 |
0.232
|
|
|
response to abiotic stimulus
|
GO:0009628 |
336 |
0.230
|
|
|
formation of primary germ layer
|
GO:0001704 |
42 |
0.224
|
|
|
regulation of mapk cascade
|
GO:0043408 |
262 |
0.222
|
|
|
regulation of cell differentiation
|
GO:0045595 |
393 |
0.218
|
|
|
heart morphogenesis
|
GO:0003007 |
48 |
0.213
|
|
|
negative regulation of leukocyte differentiation
|
GO:1902106 |
24 |
0.207
|
|
|
appendage morphogenesis
|
GO:0035107 |
16 |
0.203
|
|
|
nephron epithelium development
|
GO:0072009 |
23 |
0.198
|
|
|
neurological system process
|
GO:0050877 |
163 |
0.189
|
|
|
positive regulation of digestive system process
|
GO:0060456 |
2 |
0.188
|
|
|
eye development
|
GO:0001654 |
42 |
0.182
|
|
|
behavior
|
GO:0007610 |
112 |
0.180
|
|
|
epithelium development
|
GO:0060429 |
227 |
0.179
|
|
|
regulation of interleukin 1 mediated signaling pathway
|
GO:2000659 |
3 |
0.177
|
|
|
cell fate commitment
|
GO:0045165 |
27 |
0.174
|
|
|
endocrine system development
|
GO:0035270 |
26 |
0.174
|
|
|
tube morphogenesis
|
GO:0035239 |
95 |
0.173
|
|
|
inner ear morphogenesis
|
GO:0042472 |
4 |
0.170
|
|
|
response to cytokine
|
GO:0034097 |
232 |
0.169
|
|
|
odontogenesis
|
GO:0042476 |
25 |
0.168
|
|
|
negative regulation of mesonephros development
|
GO:0061218 |
1 |
0.159
|
|
|
midbrain development
|
GO:0030901 |
45 |
0.159
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
116 |
0.158
|
|
|
endodermal cell fate commitment
|
GO:0001711 |
4 |
0.157
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
181 |
0.152
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
24 |
0.152
|
|
|
regulation of anatomical structure morphogenesis
|
GO:0022603 |
286 |
0.151
|
|
|
head development
|
GO:0060322 |
108 |
0.142
|
|
|
canonical wnt signaling pathway involved in cardiac muscle cell fate commitment
|
GO:0061317 |
3 |
0.141
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
24 |
0.141
|
|
|
kidney epithelium development
|
GO:0072073 |
25 |
0.135
|
|
|
negative regulation of protein serine threonine kinase activity
|
GO:0071901 |
57 |
0.135
|
|
|
digestive system development
|
GO:0055123 |
75 |
0.134
|
|
|
negative regulation of kidney development
|
GO:0090185 |
2 |
0.132
|
|
|
anatomical structure formation involved in morphogenesis
|
GO:0048646 |
284 |
0.130
|
|
|
cardiovascular system development
|
GO:0072358 |
262 |
0.130
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
4 |
0.130
|
|
|
cardiocyte differentiation
|
GO:0035051 |
23 |
0.127
|
|
|
amine metabolic process
|
GO:0009308 |
44 |
0.124
|
|
|
central nervous system development
|
GO:0007417 |
123 |
0.124
|
|
|
system process
|
GO:0003008 |
349 |
0.120
|
|
|
regulation of body fluid levels
|
GO:0050878 |
99 |
0.116
|
|
|
heart formation
|
GO:0060914 |
2 |
0.116
|
|
|
negative regulation of cell death
|
GO:0060548 |
345 |
0.113
|
|
|
hematopoietic or lymphoid organ development
|
GO:0048534 |
186 |
0.112
|
|
|
secretion
|
GO:0046903 |
254 |
0.112
|
|
|
immune system development
|
GO:0002520 |
195 |
0.110
|
|
|
cranial nerve morphogenesis
|
GO:0021602 |
1 |
0.108
|
|
|
ectodermal placode formation
|
GO:0060788 |
1 |
0.104
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
113 |
0.103
|
|
|
endoderm formation
|
GO:0001706 |
33 |
0.103
|
|
|
regulation of heart morphogenesis
|
GO:2000826 |
4 |
0.102
|
|
|
polyol transport
|
GO:0015791 |
5 |
0.102
|
|
|
positive regulation of cellular component organization
|
GO:0051130 |
376 |
0.101
|
|
|
endodermal cell fate specification
|
GO:0001714 |
4 |
0.101
|
|
|
organ induction
|
GO:0001759 |
4 |
0.099
|
|
|
negative regulation of gastrulation
|
GO:2000542 |
4 |
0.099
|
|
|
pattern specification process
|
GO:0007389 |
43 |
0.098
|
|
|
mapk cascade
|
GO:0000165 |
288 |
0.097
|
|
|
neural nucleus development
|
GO:0048857 |
47 |
0.096
|
|
|
cellular component morphogenesis
|
GO:0032989 |
314 |
0.095
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
162 |
0.095
|
|
|
axis elongation
|
GO:0003401 |
4 |
0.094
|
|
|
vasculature development
|
GO:0001944 |
181 |
0.092
|
|
|
embryonic skeletal system development
|
GO:0048706 |
13 |
0.091
|
|
|
nervous system development
|
GO:0007399 |
293 |
0.089
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
353 |
0.087
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
158 |
0.087
|
|
|
i kappab kinase nf kappab signaling
|
GO:0007249 |
166 |
0.086
|
|
|
pharynx development
|
GO:0060465 |
1 |
0.085
|
|
|
ureter development
|
GO:0072189 |
3 |
0.083
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
24 |
0.082
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
391 |
0.082
|
|
|
positive regulation of mesenchymal cell proliferation
|
GO:0002053 |
2 |
0.082
|
|
|
positive regulation of cell proliferation
|
GO:0008284 |
301 |
0.078
|
|
|
eye morphogenesis
|
GO:0048592 |
16 |
0.078
|
|
|
branch elongation involved in ureteric bud branching
|
GO:0060681 |
2 |
0.078
|
|
|
response to mercury ion
|
GO:0046689 |
4 |
0.077
|
|
|
cellular response to mercury ion
|
GO:0071288 |
2 |
0.077
|
|
|
cellular amine metabolic process
|
GO:0044106 |
41 |
0.075
|
|
|
negative regulation of binding
|
GO:0051100 |
57 |
0.075
|
|
|
sensory perception
|
GO:0007600 |
103 |
0.074
|
|
|
cytokine mediated signaling pathway
|
GO:0019221 |
109 |
0.074
|
|
|
water homeostasis
|
GO:0030104 |
14 |
0.073
|
|
|
regulation of mesonephros development
|
GO:0061217 |
3 |
0.073
|
|
|
regulation of transferase activity
|
GO:0051338 |
355 |
0.072
|
|
|
long term memory
|
GO:0007616 |
2 |
0.070
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
244 |
0.070
|
|
|
sensory perception of mechanical stimulus
|
GO:0050954 |
37 |
0.069
|
|
|
cellular response to camp
|
GO:0071320 |
21 |
0.068
|
|
|
negative regulation of embryonic development
|
GO:0045992 |
4 |
0.068
|
|
|
positive regulation of embryonic development
|
GO:0040019 |
6 |
0.067
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
170 |
0.067
|
|
|
regulation of kinase activity
|
GO:0043549 |
314 |
0.066
|
|
|
nephron tubule formation
|
GO:0072079 |
1 |
0.066
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
207 |
0.064
|
|
|
visual behavior
|
GO:0007632 |
2 |
0.064
|
|
|
positive regulation of cell differentiation
|
GO:0045597 |
211 |
0.063
|
|
|
skeletal muscle satellite cell proliferation
|
GO:0014841 |
1 |
0.062
|
|
|
ectodermal placode development
|
GO:0071696 |
1 |
0.062
|
|
|
positive regulation of extrinsic apoptotic signaling pathway via death domain receptors
|
GO:1902043 |
3 |
0.062
|
|
|
embryonic skeletal system morphogenesis
|
GO:0048704 |
9 |
0.062
|
|
|
ear morphogenesis
|
GO:0042471 |
7 |
0.062
|
|
|
anion transport
|
GO:0006820 |
161 |
0.061
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
249 |
0.060
|
|
|
positive regulation of metanephros development
|
GO:0072216 |
3 |
0.060
|
|
|
embryo development
|
GO:0009790 |
123 |
0.059
|
|
|
negative regulation of sequence specific dna binding transcription factor activity
|
GO:0043433 |
89 |
0.059
|
|
|
positive regulation of mesonephros development
|
GO:0061213 |
2 |
0.059
|
|
|
negative regulation of programmed cell death
|
GO:0043069 |
321 |
0.058
|
|
|
tongue development
|
GO:0043586 |
1 |
0.058
|
|
|
receptor internalization
|
GO:0031623 |
43 |
0.058
|
|
|
basophil chemotaxis
|
GO:0002575 |
1 |
0.057
|
|
|
epithelial cell differentiation
|
GO:0030855 |
141 |
0.057
|
|
|
signal transduction by phosphorylation
|
GO:0023014 |
297 |
0.057
|
|
|
regulation of intracellular protein transport
|
GO:0033157 |
123 |
0.056
|
|
|
regulation of heart induction by regulation of canonical wnt signaling pathway
|
GO:0090081 |
1 |
0.055
|
|
|
regionalization
|
GO:0003002 |
29 |
0.054
|
|
|
cyclic nucleotide metabolic process
|
GO:0009187 |
82 |
0.054
|
|
|
positive regulation of angiogenesis
|
GO:0045766 |
51 |
0.052
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
127 |
0.052
|
|
|
negative regulation of jun kinase activity
|
GO:0043508 |
4 |
0.051
|
|
|
regulation of protein localization
|
GO:0032880 |
296 |
0.051
|
|
|
renal water homeostasis
|
GO:0003091 |
4 |
0.051
|
|
|
cell morphogenesis
|
GO:0000902 |
296 |
0.049
|
|
|
negative regulation of interleukin 1 mediated signaling pathway
|
GO:2000660 |
2 |
0.049
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
11 |
0.049
|
|
|
skeletal muscle cell proliferation
|
GO:0014856 |
1 |
0.049
|
|
|
renal system process
|
GO:0003014 |
25 |
0.049
|
|
|
chordate embryonic development
|
GO:0043009 |
34 |
0.048
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
163 |
0.047
|
|
|
positive regulation of cell development
|
GO:0010720 |
92 |
0.047
|
|
|
response to retinoic acid
|
GO:0032526 |
33 |
0.047
|
|
|
myeloid cell differentiation
|
GO:0030099 |
117 |
0.047
|
|
|
aorta morphogenesis
|
GO:0035909 |
1 |
0.046
|
|
|
response to fibroblast growth factor
|
GO:0071774 |
39 |
0.046
|
|
|
negative regulation of response to cytokine stimulus
|
GO:0060761 |
25 |
0.046
|
|
|
autonomic nervous system development
|
GO:0048483 |
1 |
0.046
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
267 |
0.046
|
|
|
associative learning
|
GO:0008306 |
1 |
0.045
|
|
|
regulation of satellite cell proliferation
|
GO:0014842 |
1 |
0.045
|
|
|
positive regulation of branching involved in ureteric bud morphogenesis
|
GO:0090190 |
2 |
0.044
|
|
|
cellular response to endogenous stimulus
|
GO:0071495 |
336 |
0.044
|
|
|
limb development
|
GO:0060173 |
23 |
0.044
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
211 |
0.044
|
|
|
positive regulation of locomotion
|
GO:0040017 |
186 |
0.044
|
|
|
metanephric nephron epithelium development
|
GO:0072243 |
4 |
0.043
|
|
|
regulation of jun kinase activity
|
GO:0043506 |
27 |
0.043
|
|
|
regulation of receptor internalization
|
GO:0002090 |
15 |
0.043
|
|
|
cochlea morphogenesis
|
GO:0090103 |
1 |
0.042
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
170 |
0.042
|
|
|
metanephros development
|
GO:0001656 |
16 |
0.042
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
267 |
0.042
|
|
|
sensory perception of sound
|
GO:0007605 |
37 |
0.042
|
|
|
blastoderm segmentation
|
GO:0007350 |
2 |
0.042
|
|
|
metencephalon development
|
GO:0022037 |
2 |
0.042
|
|
|
regulation of peptidase activity
|
GO:0052547 |
180 |
0.042
|
|
|
heart field specification
|
GO:0003128 |
2 |
0.041
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
200 |
0.041
|
|
|
enzyme linked receptor protein signaling pathway
|
GO:0007167 |
303 |
0.041
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
281 |
0.040
|
|
|
ureteric bud elongation
|
GO:0060677 |
2 |
0.040
|
|
|
hindbrain development
|
GO:0030902 |
3 |
0.040
|
|
|
inner ear development
|
GO:0048839 |
8 |
0.040
|
|
|
regulation of cell development
|
GO:0060284 |
161 |
0.039
|
|
|
stem cell development
|
GO:0048864 |
69 |
0.039
|
|
|
cell fate specification
|
GO:0001708 |
8 |
0.039
|
|
|
protein maturation
|
GO:0051604 |
233 |
0.038
|
|
|
mesenchyme development
|
GO:0060485 |
59 |
0.038
|
|
|
muscle tissue development
|
GO:0060537 |
62 |
0.038
|
|
|
eye photoreceptor cell differentiation
|
GO:0001754 |
2 |
0.038
|
|
|
glomerular mesangial cell proliferation
|
GO:0072110 |
3 |
0.038
|
|
|
tube development
|
GO:0035295 |
125 |
0.038
|
|
|
protein localization to nucleus
|
GO:0034504 |
136 |
0.038
|
|
|
ras protein signal transduction
|
GO:0007265 |
73 |
0.038
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
303 |
0.038
|
|
|
positive regulation of intracellular transport
|
GO:0032388 |
104 |
0.038
|
|
|
embryonic cranial skeleton morphogenesis
|
GO:0048701 |
6 |
0.038
|
|
|
regulation of glomerular mesangial cell proliferation
|
GO:0072124 |
3 |
0.037
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
21 |
0.037
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
116 |
0.037
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.037
|
|
|
cell adhesion
|
GO:0007155 |
325 |
0.037
|
|
|
regulation of map kinase activity
|
GO:0043405 |
108 |
0.037
|
|
|
calcium ion transport
|
GO:0006816 |
147 |
0.036
|
|
|
cellular response to tumor necrosis factor
|
GO:0071356 |
63 |
0.036
|
|
|
regulation of behavior
|
GO:0050795 |
82 |
0.036
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
125 |
0.036
|
|
|
canonical wnt signaling pathway involved in heart development
|
GO:0061316 |
3 |
0.036
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
289 |
0.036
|
|
|
cell development
|
GO:0048468 |
328 |
0.036
|
|
|
camera type eye development
|
GO:0043010 |
25 |
0.036
|
|
|
mesodermal cell fate commitment
|
GO:0001710 |
2 |
0.036
|
|
|
negative regulation of phosphatidylinositol biosynthetic process
|
GO:0010512 |
2 |
0.036
|
|
|
striated muscle cell differentiation
|
GO:0051146 |
43 |
0.036
|
|
|
positive regulation of histone deacetylase activity
|
GO:1901727 |
3 |
0.036
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
124 |
0.035
|
|
|
developmental induction
|
GO:0031128 |
5 |
0.035
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
50 |
0.035
|
|
|
negative regulation of cytokine mediated signaling pathway
|
GO:0001960 |
22 |
0.034
|
|
|
branch elongation of an epithelium
|
GO:0060602 |
3 |
0.034
|
|
|
protein localization to organelle
|
GO:0033365 |
280 |
0.034
|
|
|
endocrine pancreas development
|
GO:0031018 |
11 |
0.034
|
|
|
regulation of stress activated mapk cascade
|
GO:0032872 |
84 |
0.034
|
|
|
soft palate development
|
GO:0060023 |
3 |
0.033
|
|
|
ectodermal placode morphogenesis
|
GO:0071697 |
1 |
0.033
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
110 |
0.033
|
|
|
spermatid development
|
GO:0007286 |
4 |
0.033
|
|
|
negative regulation of apoptotic process
|
GO:0043066 |
316 |
0.033
|
|
|
actin filament based process
|
GO:0030029 |
224 |
0.033
|
|
|
thymus development
|
GO:0048538 |
3 |
0.033
|
|
|
rho protein signal transduction
|
GO:0007266 |
26 |
0.033
|
|
|
dna conformation change
|
GO:0071103 |
113 |
0.033
|
|
|
embryonic morphogenesis
|
GO:0048598 |
85 |
0.033
|
|
|
nephron tubule morphogenesis
|
GO:0072078 |
13 |
0.033
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
125 |
0.032
|
|
|
regulation of embryonic development
|
GO:0045995 |
20 |
0.032
|
|
|
protein processing
|
GO:0016485 |
226 |
0.032
|
|
|
glycerolipid biosynthetic process
|
GO:0045017 |
51 |
0.032
|
|
|
renal system process involved in regulation of blood volume
|
GO:0001977 |
4 |
0.032
|
|
|
negative regulation of cell fate specification
|
GO:0009996 |
3 |
0.032
|
|
|
spermatid differentiation
|
GO:0048515 |
4 |
0.032
|
|
|
neuromuscular junction development
|
GO:0007528 |
3 |
0.032
|
|
|
regulation of glomerulus development
|
GO:0090192 |
3 |
0.032
|
|
|
artery morphogenesis
|
GO:0048844 |
7 |
0.031
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.031
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.031
|
|
|
response to wounding
|
GO:0009611 |
168 |
0.031
|
|
|
phospholipid metabolic process
|
GO:0006644 |
99 |
0.031
|
|
|
peripheral nervous system development
|
GO:0007422 |
2 |
0.031
|
|
|
regulation of muscle tissue development
|
GO:1901861 |
26 |
0.031
|
|
|
cellular response to interleukin 1
|
GO:0071347 |
35 |
0.031
|
|
|
developmental programmed cell death
|
GO:0010623 |
3 |
0.031
|
|
|
sensory perception of chemical stimulus
|
GO:0007606 |
38 |
0.031
|
|
|
anterior posterior axis specification
|
GO:0009948 |
2 |
0.031
|
|
|
digestion
|
GO:0007586 |
22 |
0.031
|
|
|
positive regulation of protein complex assembly
|
GO:0031334 |
86 |
0.031
|
|
|
vascular wound healing
|
GO:0061042 |
4 |
0.031
|
|
|
branching involved in salivary gland morphogenesis
|
GO:0060445 |
1 |
0.031
|
|
|
muscle cell proliferation
|
GO:0033002 |
35 |
0.031
|
|
|
myoblast fusion
|
GO:0007520 |
1 |
0.031
|
|
|
response to lipid
|
GO:0033993 |
206 |
0.031
|
|
|
muscle structure development
|
GO:0061061 |
98 |
0.031
|
|
|
cartilage condensation
|
GO:0001502 |
1 |
0.031
|
|
|
renal tubule development
|
GO:0061326 |
19 |
0.031
|
|
|
response to radiation
|
GO:0009314 |
151 |
0.030
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
246 |
0.030
|
|
|
substantia nigra development
|
GO:0021762 |
45 |
0.030
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
183 |
0.030
|
|
|
cellular response to oxygen containing compound
|
GO:1901701 |
276 |
0.030
|
|
|
transmembrane transport
|
GO:0055085 |
399 |
0.030
|
|
|
cellular response to inorganic substance
|
GO:0071241 |
45 |
0.029
|
|
|
cell junction organization
|
GO:0034330 |
79 |
0.029
|
|
|
regulation of endodermal cell fate specification
|
GO:0042663 |
1 |
0.029
|
|
|
positive regulation of stem cell differentiation
|
GO:2000738 |
29 |
0.029
|
|
|
positive regulation of canonical wnt signaling pathway
|
GO:0090263 |
33 |
0.029
|
|
|
regulation of striated muscle tissue development
|
GO:0016202 |
26 |
0.029
|
|
|
hemopoiesis
|
GO:0030097 |
180 |
0.029
|
|
|
regulation of jnk cascade
|
GO:0046328 |
73 |
0.029
|
|
|
regulation of myoblast fusion
|
GO:1901739 |
1 |
0.029
|
|
|
regulation of cell migration
|
GO:0030334 |
289 |
0.029
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
75 |
0.028
|
|
|
regulation of wnt signaling pathway involved in heart development
|
GO:0003307 |
3 |
0.028
|
|
|
regulation of endodermal cell differentiation
|
GO:1903224 |
3 |
0.028
|
|
|
forebrain development
|
GO:0030900 |
26 |
0.028
|
|
|
negative regulation of cell cycle phase transition
|
GO:1901988 |
89 |
0.028
|
|
|
ossification
|
GO:0001503 |
121 |
0.028
|
|
|
nucleoside phosphate biosynthetic process
|
GO:1901293 |
109 |
0.028
|
|
|
regulation of cysteine type endopeptidase activity
|
GO:2000116 |
127 |
0.028
|
|
|
biological adhesion
|
GO:0022610 |
331 |
0.028
|
|
|
cell morphogenesis involved in differentiation
|
GO:0000904 |
144 |
0.028
|
|
|
regulation of myeloid leukocyte differentiation
|
GO:0002761 |
39 |
0.028
|
|
|
regulation of intracellular transport
|
GO:0032386 |
195 |
0.028
|
|
|
positive regulation of proteolysis
|
GO:0045862 |
142 |
0.028
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
179 |
0.028
|
|
|
regulation of cell substrate adhesion
|
GO:0010810 |
68 |
0.028
|
|
|
cell fate determination
|
GO:0001709 |
3 |
0.028
|
|
|
regulation of protein complex assembly
|
GO:0043254 |
147 |
0.027
|
|
|
protein localization to early endosome
|
GO:1902946 |
2 |
0.027
|
|
|
stem cell division
|
GO:0017145 |
2 |
0.027
|
|
|
negative regulation of canonical wnt signaling pathway
|
GO:0090090 |
55 |
0.026
|
|
|
embryonic placenta development
|
GO:0001892 |
1 |
0.026
|
|
|
glycerophospholipid biosynthetic process
|
GO:0046474 |
40 |
0.026
|
|
|
response to organic cyclic compound
|
GO:0014070 |
204 |
0.026
|
|
|
regulation of stem cell differentiation
|
GO:2000736 |
56 |
0.026
|
|
|
somatic muscle development
|
GO:0007525 |
1 |
0.026
|
|
|
response to nitric oxide
|
GO:0071731 |
4 |
0.026
|
|
|
positive regulation of peptidyl tyrosine phosphorylation
|
GO:0050731 |
85 |
0.026
|
|
|
syncytium formation by plasma membrane fusion
|
GO:0000768 |
2 |
0.025
|
|
|
erk1 and erk2 cascade
|
GO:0070371 |
104 |
0.025
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
158 |
0.025
|
|
|
cellular response to metal ion
|
GO:0071248 |
43 |
0.025
|
|
|
negative regulation of wnt signaling pathway
|
GO:0030178 |
69 |
0.025
|
|
|
cellular response to oxygen levels
|
GO:0071453 |
55 |
0.025
|
|
|
determination of adult lifespan
|
GO:0008340 |
2 |
0.025
|
|
|
osteoclast differentiation
|
GO:0030316 |
21 |
0.025
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
331 |
0.024
|
|
|
somatic stem cell maintenance
|
GO:0035019 |
4 |
0.024
|
|
|
cell aggregation
|
GO:0098743 |
1 |
0.024
|
|
|
regulation of angiogenesis
|
GO:0045765 |
92 |
0.024
|
|
|
angiogenesis involved in wound healing
|
GO:0060055 |
4 |
0.024
|
|
|
cell cell signaling
|
GO:0007267 |
155 |
0.024
|
|
|
regulation of immune response
|
GO:0050776 |
201 |
0.024
|
|
|
lipid biosynthetic process
|
GO:0008610 |
177 |
0.024
|
|
|
metanephric glomerulus development
|
GO:0072224 |
2 |
0.023
|
|
|
response to mechanical stimulus
|
GO:0009612 |
51 |
0.023
|
|
|
response to interleukin 1
|
GO:0070555 |
47 |
0.023
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
140 |
0.023
|
|
|
nuclear transport
|
GO:0051169 |
179 |
0.023
|
|
|
fibroblast growth factor receptor signaling pathway
|
GO:0008543 |
26 |
0.023
|
|
|
negative regulation of multicellular organismal process
|
GO:0051241 |
317 |
0.023
|
|
|
negative regulation of stress activated mapk cascade
|
GO:0032873 |
19 |
0.023
|
|
|
positive regulation of myotube differentiation
|
GO:0010831 |
3 |
0.023
|
|
|
response to inorganic substance
|
GO:0010035 |
127 |
0.023
|
|
|
digestive tract development
|
GO:0048565 |
75 |
0.022
|
|
|
regulation of tumor necrosis factor mediated signaling pathway
|
GO:0010803 |
12 |
0.022
|
|
|
nitrogen compound transport
|
GO:0071705 |
191 |
0.022
|
|
|
regulation of syncytium formation by plasma membrane fusion
|
GO:0060142 |
2 |
0.022
|
|
|
regulation of proteolysis
|
GO:0030162 |
293 |
0.022
|
|
|
negative regulation of catalytic activity
|
GO:0043086 |
335 |
0.022
|
|
|
positive regulation of mesenchymal stem cell differentiation
|
GO:2000741 |
4 |
0.022
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
7 |
0.022
|
|
|
heart induction
|
GO:0003129 |
4 |
0.022
|
|
|
microtubule based process
|
GO:0007017 |
210 |
0.022
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
130 |
0.022
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
60 |
0.022
|
|
|
regulation of adherens junction organization
|
GO:1903391 |
21 |
0.022
|
|
|
regulation of skeletal muscle cell differentiation
|
GO:2001014 |
3 |
0.022
|
|
|
post embryonic organ development
|
GO:0048569 |
1 |
0.022
|
|
|
blood vessel development
|
GO:0001568 |
172 |
0.022
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
21 |
0.022
|
|
|
ureteric bud development
|
GO:0001657 |
13 |
0.022
|
|
|
response to decreased oxygen levels
|
GO:0036293 |
96 |
0.022
|
|
|
stress activated mapk cascade
|
GO:0051403 |
93 |
0.022
|
|
|
regulation of actin cytoskeleton organization
|
GO:0032956 |
116 |
0.021
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
19 |
0.021
|
|
|
positive regulation of fibroblast growth factor receptor signaling pathway
|
GO:0045743 |
3 |
0.021
|
|
|
mitochondrion organization
|
GO:0007005 |
156 |
0.021
|
|
|
regulation of nervous system development
|
GO:0051960 |
88 |
0.021
|
|
|
striated muscle tissue development
|
GO:0014706 |
59 |
0.021
|
|
|
coagulation
|
GO:0050817 |
78 |
0.021
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
200 |
0.021
|
|
|
oocyte differentiation
|
GO:0009994 |
2 |
0.021
|
|
|
pharyngeal system development
|
GO:0060037 |
2 |
0.021
|
|
|
regulation of erk1 and erk2 cascade
|
GO:0070372 |
99 |
0.021
|
|
|
regulation of binding
|
GO:0051098 |
111 |
0.021
|
|
|
mitotic cell cycle
|
GO:0000278 |
326 |
0.021
|
|
|
rna processing
|
GO:0006396 |
255 |
0.021
|
|
|
nucleotide biosynthetic process
|
GO:0009165 |
109 |
0.021
|
|
|
regulation of gastrulation
|
GO:0010470 |
12 |
0.021
|
|
|
positive regulation of wnt signaling pathway
|
GO:0030177 |
54 |
0.021
|
|
|
epithelial cell proliferation
|
GO:0050673 |
128 |
0.021
|
|
|
regulation of protein import into nucleus
|
GO:0042306 |
78 |
0.021
|
|
|
carboxylic acid biosynthetic process
|
GO:0046394 |
97 |
0.021
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
38 |
0.021
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
170 |
0.020
|
|
|
anterior posterior axis specification embryo
|
GO:0008595 |
2 |
0.020
|
|
|
negative regulation of proteolysis
|
GO:0045861 |
132 |
0.020
|
|
|
negative regulation of kinase activity
|
GO:0033673 |
106 |
0.020
|
|
|
cellular response to external stimulus
|
GO:0071496 |
111 |
0.020
|
|
|
cellular macromolecular complex assembly
|
GO:0034622 |
324 |
0.020
|
|
|
rna splicing
|
GO:0008380 |
131 |
0.020
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
174 |
0.020
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
39 |
0.020
|
|
|
immune response
|
GO:0006955 |
307 |
0.020
|
|
|
jnk cascade
|
GO:0007254 |
80 |
0.020
|
|
|
lipid metabolic process
|
GO:0006629 |
381 |
0.020
|
|
|
protein targeting
|
GO:0006605 |
187 |
0.020
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
61 |
0.020
|
|
|
cardiac muscle cell contraction
|
GO:0086003 |
4 |
0.020
|
|
|
stress activated protein kinase signaling cascade
|
GO:0031098 |
94 |
0.020
|
|
|
positive regulation of apoptotic signaling pathway
|
GO:2001235 |
70 |
0.020
|
|
|
oocyte development
|
GO:0048599 |
1 |
0.019
|
|
|
regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043281 |
116 |
0.019
|
|
|
regulation of striated muscle cell differentiation
|
GO:0051153 |
25 |
0.019
|
|
|
response to growth factor
|
GO:0070848 |
205 |
0.019
|
|
|
regulation of actin filament based process
|
GO:0032970 |
141 |
0.019
|
|
|
negative regulation of hydrolase activity
|
GO:0051346 |
182 |
0.019
|
|
|
positive regulation of cell death
|
GO:0010942 |
263 |
0.019
|
|
|
tripartite regional subdivision
|
GO:0007351 |
2 |
0.019
|
|
|
response to ionizing radiation
|
GO:0010212 |
65 |
0.019
|
|
|
somitogenesis
|
GO:0001756 |
2 |
0.019
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
149 |
0.019
|
|
|
regulation of cell proliferation involved in kidney development
|
GO:1901722 |
3 |
0.019
|
|
|
cellular response to decreased oxygen levels
|
GO:0036294 |
51 |
0.019
|
|
|
response to tumor necrosis factor
|
GO:0034612 |
76 |
0.019
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
342 |
0.019
|
|
|
regulation of metanephric mesenchymal cell migration by platelet derived growth factor receptor beta signaling pathway
|
GO:1900238 |
2 |
0.019
|
|
|
canonical wnt signaling pathway involved in osteoblast differentiation
|
GO:0044339 |
2 |
0.018
|
|
|
multicellular organismal water homeostasis
|
GO:0050891 |
14 |
0.018
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
40 |
0.018
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
6 |
0.018
|
|
|
response to copper ion
|
GO:0046688 |
8 |
0.018
|
|
|
somite development
|
GO:0061053 |
7 |
0.018
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.018
|
|
|
cell migration involved in kidney development
|
GO:0035787 |
2 |
0.018
|
|
|
cell substrate junction assembly
|
GO:0007044 |
35 |
0.018
|
|
|
cyclic nucleotide biosynthetic process
|
GO:0009190 |
61 |
0.018
|
|
|
generation of neurons
|
GO:0048699 |
152 |
0.018
|
|
|
regulation of heart induction
|
GO:0090381 |
2 |
0.018
|
|
|
cell projection assembly
|
GO:0030031 |
126 |
0.018
|
|
|
smooth muscle tissue development
|
GO:0048745 |
3 |
0.018
|
|
|
taxis
|
GO:0042330 |
157 |
0.018
|
|
|
regulation of i kappab kinase nf kappab signaling
|
GO:0043122 |
162 |
0.018
|
|
|
endothelial cell migration
|
GO:0043542 |
86 |
0.018
|
|
|
wound healing
|
GO:0042060 |
115 |
0.018
|
|
|
embryo development ending in birth or egg hatching
|
GO:0009792 |
34 |
0.018
|
|
|
response to dexamethasone
|
GO:0071548 |
1 |
0.017
|
|
|
positive regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043280 |
69 |
0.017
|
|
|
cellular response to lipid
|
GO:0071396 |
127 |
0.017
|
|
|
response to purine containing compound
|
GO:0014074 |
40 |
0.017
|
|
|
regulation of mesodermal cell fate specification
|
GO:0042661 |
2 |
0.017
|
|
|
organic acid biosynthetic process
|
GO:0016053 |
97 |
0.017
|
|
|
positive regulation of phosphorylation
|
GO:0042327 |
394 |
0.017
|
|
|
tube closure
|
GO:0060606 |
3 |
0.017
|
|
|
gastrulation
|
GO:0007369 |
51 |
0.017
|
|
|
oogenesis
|
GO:0048477 |
2 |
0.017
|
|
|
regulation of neurogenesis
|
GO:0050767 |
82 |
0.017
|
|
|
negative regulation of transferase activity
|
GO:0051348 |
124 |
0.017
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
83 |
0.017
|
|
|
epithelial cell development
|
GO:0002064 |
34 |
0.017
|
|
|
response to acid chemical
|
GO:0001101 |
66 |
0.017
|
|
|
muscle cell development
|
GO:0055001 |
29 |
0.017
|
|
|
mesonephric tubule development
|
GO:0072164 |
14 |
0.017
|
|
|
receptor metabolic process
|
GO:0043112 |
81 |
0.017
|
|
|
integrin mediated signaling pathway
|
GO:0007229 |
32 |
0.017
|
|
|
regulation of heart growth
|
GO:0060420 |
4 |
0.016
|
|
|
negative regulation of myeloid leukocyte differentiation
|
GO:0002762 |
16 |
0.016
|
|
|
regulation of osteoclast differentiation
|
GO:0045670 |
18 |
0.016
|
|
|
hair cycle
|
GO:0042633 |
28 |
0.016
|
|
|
regulation of cell cycle phase transition
|
GO:1901987 |
126 |
0.016
|
|
|
salivary gland morphogenesis
|
GO:0007435 |
4 |
0.016
|
|
|
regulation of small gtpase mediated signal transduction
|
GO:0051056 |
156 |
0.016
|
|
|
cellular response to acid chemical
|
GO:0071229 |
44 |
0.016
|
|
|
neurogenesis
|
GO:0022008 |
169 |
0.016
|
|
|
response to salt stress
|
GO:0009651 |
3 |
0.016
|
|
|
response to organonitrogen compound
|
GO:0010243 |
156 |
0.016
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
207 |
0.016
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
78 |
0.016
|
|
|
female gamete generation
|
GO:0007292 |
2 |
0.016
|
|
|
cardiac muscle cell differentiation
|
GO:0055007 |
15 |
0.016
|
|
|
cell growth
|
GO:0016049 |
160 |
0.016
|
|
|
response to oxygen levels
|
GO:0070482 |
100 |
0.016
|
|
|
regulation of protein localization to nucleus
|
GO:1900180 |
85 |
0.016
|
|
|
response to steroid hormone
|
GO:0048545 |
80 |
0.015
|
|
|
neural tube closure
|
GO:0001843 |
3 |
0.015
|
|
|
negative regulation of nf kappab transcription factor activity
|
GO:0032088 |
51 |
0.015
|
|
|
adherens junction assembly
|
GO:0034333 |
34 |
0.015
|
|
|
chemical homeostasis
|
GO:0048878 |
306 |
0.015
|
|